Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer
Condition(s):Prostate Cancer MetastaticLast Updated:October 14, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Prostate Cancer MetastaticLast Updated:October 14, 2021Unknown status
Condition(s):Prostate Cancer; Bone Metastases; Prostate NeoplasmsLast Updated:July 11, 2022Terminated
Condition(s):Metastatic Prostate CancerLast Updated:November 5, 2015Completed
Condition(s):Bone Metastases; Prostate CancerLast Updated:November 4, 2020Completed
Condition(s):Prostate Carcinoma Metastatic to the BoneLast Updated:March 19, 2019Completed
Condition(s):Prostate CancerLast Updated:March 6, 2024Completed
Condition(s):Prostate CancerLast Updated:September 18, 2018Completed
Condition(s):Hormone Refractory Prostate CancerLast Updated:October 17, 2018Completed
Condition(s):Prostate CancerLast Updated:November 18, 2016Completed
Condition(s):Bone Metastases; Castration-Resistant Prostate CancerLast Updated:January 4, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.